Overview

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study will provide data on the addition of narrow band ultra violet B (nbUVB) phototherapy to participants who have not shown an excellent response to three months of etanercept.
Phase:
Phase 4
Details
Lead Sponsor:
Innovaderm Research Inc.
Collaborator:
Amgen
Treatments:
Etanercept